Breast Cancer Clinical Trial
Official title:
Pink Warrior—Support Group Toolkit for Breast Cancer Survivors
Breast cancer survivors, from diagnosis until the end of life, go through many transitions.
One major transition is the significant decrease of physical activity immediately after
diagnosis. Despite the known benefits of physical activity—speeding recovery time and reduced
cancer recurrence risk—only 1 in 3 survivors met physical activity recommendations of 150
minutes of moderate-intensity activity per week. Physical activity interventions have shown
effectiveness in helping breast cancer survivors increase physical activity during treatment,
but limited evidence-based physical activity interventions have been incorporated into the
clinic and community. To address this limitation, the investigators are partnering with the
UTMB breast cancer support group to conduct a 12-week physical activity intervention, Pink
Warrior.
The goal of this study is to compare an intervention that uses active games versus an
intervention uses pedometer to encourage physical activity such as walking within breast
cancer survivors in active cancer treatment. The study will include breast cancer survivor
between the ages of 18 - 70 whom currently gets less than 150 minutes of planned physical
activity per week and received a breast cancer diagnosis within 0 to 6 months. Participants
will be randomized to participate in the support group using the active video game-based
physical activity intervention (Wii and Xbox active games) or to participate in the existing
UTMB breast cancer support group with pedometers (Digi-Walker CW-700/701). The investigators
hypothesize that by engaging in active video gaming, breast cancer survivors will be
motivated to initiate and maintain physical activity during treatment. This will ultimately
increase functional capacity and prevent functional disability in breast cancer survivors.
Increasing and maintaining physical activity among female breast cancer (BC) survivors during
treatment remains an unresolved problem in BC survivorship care. BC survivors, from diagnosis
until the end of life, go through many transitions. One major transition is the significant
decline of physical activity immediately after diagnosis. Despite the known benefits of
physical activity—speeding recovery time and reduced cancer recurrence risk—less than 30% of
survivors met physical activity recommendations. Physical activity interventions have shown
effectiveness in helping BC survivors increase activity during treatment, but limited
evidence-based activity interventions have been disseminated into the clinic and community.
To address this limitation, we are partnering with the UTMB breast cancer support group to
conduct a 12-week physical activity intervention, Pink Warrior, which will investigate the
feasibility of implementing active video game-based physical activity intervention among BC
survivors undergoing treatment within the support group setting. Participants (N = 60) will
be randomized to participate in the support group using the active video game-based physical
activity intervention or to participate in the existing UTMB breast cancer support group with
pedometers. Our specific aims are:
Aim 1: Evaluate the feasibility and acceptability of active video game-based physical
activity intervention among BC survivors undergoing treatment within the support group
setting. Measures of feasibility will include weekly attendance records, number of completed
home-based worksheets, number of participants completing the program activities,
technological issues, and adverse events.
Aim 2: Compare the support group using the active video game-based physical activity
intervention to the existing UTMB breast cancer support group with pedometer. Primary
outcomes will be changes in physical activity. Secondary outcomes will be changes in physical
function, dietary pattern, and quality of life.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A | |
Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A |